Company / CapEx per Share
Whitehawk Therapeutics, Inc. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.07
FY2025
5-year range
$0.02 / $0.16
FY2021-FY2025
Trend
-58.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2018 to $0.16 in FY2024.
Based on SEC 10-K filings.
0.07 in FY2025 with a 5-year CAGR of +62.9%.
Improved from $0.02 to $0.07 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +53.9%
- 5-Year CAGR
- +62.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share decreased 58.6% year-over-year.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | -58.6% |
| FY2024 | $0.16 | +790.3% |
| FY2023 | $0.02 | -1.2% |
| FY2022 | $0.02 | +1.7% |
| FY2021 | $0.02 | +209.9% |
| FY2020 | $0.01 | +525.0% |
| FY2019 | $0.00 | +184.2% |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026